C4 Therapeutics (CCCC) Cash & Equivalents Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - | 19.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.46% |
| Dec 31, 2025 | 34.42% |
| Sep 30, 2025 | -1.41% |
| Jun 30, 2025 | 6.90% |
| Mar 31, 2025 | -42.79% |
| Dec 31, 2024 | -56.16% |
| Sep 30, 2024 | -2.17% |
| Jun 30, 2024 | 62.91% |
| Mar 31, 2024 | 81.22% |
| Dec 31, 2023 | 325.46% |
| Sep 30, 2023 | 23.05% |
| Jun 30, 2023 | -21.67% |
| Mar 31, 2023 | 7.55% |
| Dec 31, 2022 | -60.91% |
| Sep 30, 2022 | -69.55% |
| Jun 30, 2022 | -79.62% |
| Mar 31, 2022 | -51.53% |
| Dec 31, 2021 | -58.11% |
| Sep 30, 2021 | 156.56% |
| Jun 30, 2021 | 161.16% |
| Mar 31, 2021 | 28.51% |
| Dec 31, 2020 | 100.69% |
| Sep 30, 2020 | -37.18% |